Used in the synthesis of pharmaceutical intermediates, particularly in the development of protease inhibitors. Shows potential in research for treating hepatitis C due to its chiral structure and ability to bind selectively to enzyme active sites. Also employed in studies focusing on structure-activity relationships of ketoamide-based compounds. Its bromophenyl group facilitates further functionalization through cross-coupling reactions, making it valuable in medicinal chemistry for optimizing drug candidates.